Structure Therapeutics Inc. (GPCR) Corporate Subsidiaries
Structure Therapeutics Inc. (GPCR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: GPCR
CIK: 1888886
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: E9
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerRichard Ramko
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-22 | 2026-09-18 | 4 Filing | 0002037144-26-000004 | View SEC Doc Filr Page |
| 144 | 2026-09-21 | — | 144 Filing | 0001950047-26-009722 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-08 | FORM 8-K | 0001104659-26-105688 | View SEC Doc Filr Page |
| 4 | 2026-09-02 | 2026-09-01 | 4 Filing | 0001962926-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-18 | 4 Filing | 0001962926-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | 4 Filing | 0002148420-26-000006 | View SEC Doc Filr Page |
| 3 | 2026-08-07 | 2026-08-06 | 3 Filing | 0002148420-26-000005 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001104659-26-092057 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | FORM 8-K | 0001104659-26-092017 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-06 | — | SCHEDULE 13G/A Filing | 0000315066-26-002142 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-04 | 4 Filing | 0001962926-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-22 | 4 | 0001193125-26-315240 | View SEC Doc Filr Page |
| 4 | 2026-07-15 | 2026-07-14 | 4 Filing | 0001962926-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-25 | 4 Filing | 0001962926-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-06-25 | — | 144 Filing | 0001950047-26-006512 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | 4 Filing | 0001534002-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | 4 Filing | 0001188919-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | 4 Filing | 0001962413-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | 4 Filing | 0001202785-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | 4 Filing | 0001328565-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-06-17 | 4 Filing | 0001206199-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-17 | FORM 8-K | 0001104659-26-075720 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001104659-26-057230 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | FORM 8-K | 0001104659-26-057226 | View SEC Doc Filr Page |
| 424B5 | 2026-05-07 | — | 424B5 | 0001104659-26-057160 | View SEC Doc Filr Page |